Citius Oncology, Inc. Net Asset Momentum
Citius Oncology, Inc. net asset momentum. Citius Oncology, Inc. (CTOR) recorded a net asset momentum of -2.8% as of September 2025, with net assets of $44.87 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore CTOR capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Citius Oncology, Inc. (2022–2025)
Net asset momentum of Citius Oncology, Inc. from 2022 to 2025. This chart tracks Citius Oncology, Inc.'s year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -2.8%, with net assets of $44.87 Million USD as of September 2025. See CTOR net asset value for net asset value and shareholders' equity analysis.
Citius Oncology, Inc. Net Asset Momentum by Year (2022–2025)
Citius Oncology, Inc. net asset momentum by year from 2022 to 2025. The table below shows the complete annual net asset history for Citius Oncology, Inc. from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is Citius Oncology, Inc. worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $44.87 Million | $100.94 Million | $56.08 Million | ▼ -2.8% |
| 2024 | $46.14 Million | $84.37 Million | $38.23 Million | ▲ +80.7% |
| 2023 | $25.54 Million | $47.73 Million | $22.20 Million | ▼ -29.6% |
| 2022 | $36.27 Million | $42.69 Million | $6.42 Million | — |